⬇️ 下载 PDF
红蓝生物

🧬 Emibetuzumab ELISA试剂盒(靶标:)

Emibetuzumab ELISA Kit

货号: RB9T37014642
💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
🏷️ 产品编码
RB9T37014642
🧬 中文名称
Emibetuzumab ELISA试剂盒(靶标:)
📝 英文名称
Emibetuzumab ELISA Kit
🔬 应用
ELISA
🔢 登录号
P08581
🔹 检测方法
Colorimetric
🔹 灵敏度
0.156 μg/ml
🔹 检测范围
0.31-5 μg/mL
🔹 回收率
80-120%
🔹 样本类型
Plasma, Serum
🔹 检测类型
Quantitative
🔹 背景信息
Emibetuzumab (as known as LY2875358) is a humanized immunoglobulin G4 monoclonal bivalent anti-MET antibody that blocks MET signaling. This drug was developed by Eli Lilly & Company and has been used in trials studying the treatment of Advanced Cancer, Renal Cell Carcinoma, Hepatocellular Cancer, Gastric Adenocarcinoma, and Non-Small Cell Lung Cancer, among others. In preclinical models, emibetuzumab inhibited growth of tumors that are dependent on MET, including tumors that exhibit HGF-dependent and HGF-independent biology. Administration of a single dose of emibetuzumab resulted in continuous reduction of MET protein expression for 14 days in mouse xenografts. Emibetuzumab demonstrated dose-dependent, single-agent activity in various MET-expressing tumor models, and additive effects were observed in combination with erlotinib for reducing tumor volume in lung cancer mouse xenograft models. In Phase 1 dose escalation studies, emibetuzumab monotherapy was well tolerated in patients with advanced solid tumors, including gastric cancer, with no dose-limiting toxicities.
🏷️ 别名
LA480, LY-2875358, 1365287-97-3
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.